https://www.recode.net/2018/5/15/17354538/beth-seidenberg-life-sciences-kleiner-perkins-departure

One of the most prominent biotech investors in Silicon Valley, Beth Seidenberg, will be stepping down from her day-to-day role at Kleiner Perkins Caufield and Byers in the latest turnover at the venture capital firm, Recode has learned.

Seidenberg, one of nine general partners at Kleiner, is raising money to start her own firm to focus on biotech and health investing, according to people familiar with her plans. The only Kleiner general partner who expressly focuses on life sciences, Seidenberg will soon split her time and her eventual exit will inevitably raise some questions about Kleiner’s commitment to that type of venture investing.